Neonatal murine keratinocytes split express CD80/CD86 upon culture.
- Author:
Jianjun LEI
1
;
Jingqiu CHENG
;
Youping LI
;
Shengfu LI
;
Li ZHANG
Author Information
1. Key Lab of Transplant Engineering and Immunology MOH, West China Hospital, Sichuan University, Chengdu 610041, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Animals, Newborn;
Antigen-Presenting Cells;
cytology;
B7-1 Antigen;
biosynthesis;
genetics;
B7-2 Antigen;
biosynthesis;
genetics;
Cells, Cultured;
Graft Rejection;
Keratinocytes;
cytology;
Lymphocyte Activation;
Lymphocytes;
immunology;
Mice;
Mice, Inbred BALB C;
RNA, Messenger;
biosynthesis;
genetics;
Skin;
cytology
- From:
Journal of Biomedical Engineering
2005;22(2):265-270
- CountryChina
- Language:Chinese
-
Abstract:
It was previously thought that keratinocytes did not express the CD80 and CD86 which provide the most important costimulatory signals for the antigen-specific T-cell activation. The cultured keratinocytes allografts were initially accepted, but eventually, all grafted donor cells were gradually replaced by recipient cells. The precise mechanisms are not very clear. In this study, neonatal murine keratinocytes were cultured for 7 days, the results of flow cytometry and confocal microscopy showed that CD80 could be detected on keratinocytes, while CD86 could not be detected all the time. RT-PCR analysis confirmed this result. The expression level of the CD80 mRNA amplified significantly from day 1 to day 7, as expression of the control beta-actin, but CD86 was not detected. Mixed Lymphocyte Reaction (MLR) showed that keratinocytes cultured with 10% serum for 7 d stimulated effectively allogeneic rather than syngeneic T cell proliferation. This study demonstrated for the first time that costimulatory molecule CD80 can be expressed on keratinocytes in vitro. These data provided an alternative explanation for the ultimate rejection of allogeneic keratinocytes in which keratinocytes act as antigen-presenting cells.
